Navigation Links
Rigel Will Present Clinical Product Portfolio Update at J.P. Morgan Healthcare Conference
Date:1/10/2014

ill," "may," "expect," and similar expressions are intended to identify these forward-looking statements.  These forward-looking statements are based on Rigel's current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, the availability of resources to develop Rigel's product candidates, Rigel's need for additional capital in the future to sufficiently fund Rigel's operations and research, the uncertain timing of completion of and the success of clinical trials, market competition, risks associated with and Rigel's dependence on Rigel's corporate partnerships, as well as other risks detailed from time to time in Rigel's reports filed with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended September 30, 2013. Rigel does not undertake any obligation to update forward-looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein.

Contact: Raul Rodriguez
Phone: 650.624.1302
Email: invrel@rigel.com

Media Contact: Susan C. Rogers, Rivily, Inc.
Phone: 650.430.3777
Email: susan@rivily.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rigel to Present at Oppenheimer Healthcare Conference
2. Rigel Announces Third Quarter 2013 Financial Results
3. Rigel Provides Pipeline Update
4. Rigel to Present at Stifel Healthcare Conference
5. Rigel To Focus On ITP, DLE And Dry Eye
6. Rigels R343 Did Not Meet Primary Endpoint in Asthma Study
7. Rigel Announces Second Quarter 2013 Financial Results
8. Rigel Will Resume Responsibility for Fostamatinib Program
9. Rigels R348 to Initiate Phase 2 Clinical Trial in Dry Eye
10. Rigel Announces First Quarter 2013 Financial Results
11. Rigel Announces Fourth Quarter and Year End 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... treat obesity, metabolic diseases and other gastrointestinal disorders, today ... President and Chief Executive Officer, is scheduled to present ... Conference on Thursday, August 13, 2015 at 11:30 pm ... MA. Dr. Knudson will ...
(Date:8/5/2015)... BANGALORE , August 5, 2015 ... Ampoules and Blister Packaging Market segmented by Packaging ... Blister (PP, PET, PVC) - By Geographical Region ( ... , APAC, Middle East & ... Profiles, Global Market Size, Forecasts & Analysis (2015-2020). ...
(Date:8/4/2015)... 2015  Eli Lilly and Company (NYSE: LLY ... (UCSD) of its intent to end its contract with ... in Asymptomatic Alzheimer,s disease (A4) study. The A4 study ... preclinical stage of Alzheimer,s disease in older individuals who ... PET scan, but do not show symptoms of memory ...
Breaking Medicine Technology:EnteroMedics to Present at the Canaccord Genuity 35th Annual Growth Conference 2EnteroMedics to Present at the Canaccord Genuity 35th Annual Growth Conference 3DuPont, Mitsubishi Chemical Holdings and Amcor Among Other Organizations are Expected to Invest in the Asia-Pacific and Latin American Ampoules Packaging Market 2DuPont, Mitsubishi Chemical Holdings and Amcor Among Other Organizations are Expected to Invest in the Asia-Pacific and Latin American Ampoules Packaging Market 3Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3
... ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 ... of an agreement to provide extended bioinformatics genomics services ... at Ambry. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090428/LA06744LOGO ... team at Ambry has been providing genomics solutions on ...
... , DOYLESTOWN, Pa., ... Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced ... opportunities to develop prescription pharmaceutical and OTC products and has ... primarily on the OTC/Personal Care marketplace, which may include but ...
Cached Medicine Technology:Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3
(Date:8/5/2015)... ... 05, 2015 , ... Employee Fiduciary has announced the launch ... Financial is a registered investment advisor, serving 401k and other types of retirement ... values and services , providing low-cost, fiduciary–grade investment advice to its clients. ...
(Date:8/5/2015)... ... August 05, 2015 , ... The June 6 opening of Chicago’s new elevated trail, ... didn’t escape the notice of a group of walkers at Sedgebrook senior living community in ... in Lake County’s nearby forest preserves and twice per month to more distant places. ...
(Date:8/5/2015)... ... , ... Stelari introduces their new collection, The Earth’s Song, inspired by the ... Earth’s Song. Combining fashion and activewear, Stelari’s new collection let’s you take your bohemian ... this collection is sure to make the spirit seeker swoon with prints as meaningful ...
(Date:8/5/2015)... ... August 05, 2015 , ... As the nation’s ... awareness, education and support in order to reduce the incidence of brain aneurysms ... this year it has awarded the most funding in the 20-year history of ...
(Date:8/4/2015)... ... August 05, 2015 , ... MONTICELLO, Fla. – After completing 2,400 hours in ... Hospital, this journey as a clinician allowed Dr. Barbara Thomas-Reddick to gain ... to care for patients, families, friends and staff, and she was able to witness ...
Breaking Medicine News(10 mins):Health News:Employee Fiduciary Announces Subsidiary 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 3Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 4Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 2Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 3
... ... of world attention. African leaders resident in the U.S. Capitol re-committed to mobilize ... Goals (MDGs) and to replenish The Global Fund to fight AIDS, Tuberculosis and Malaria ... Washington, DC ...
... A trial on shunts used to direct blood flow ... of Michigan,s C.S. Mott Children,s Hospital, will lead to ... heart syndrome, the most common severe heart birth defect. ... the first multi-institutional randomized prospective trial ever conducted in ...
... better treatments down the road, researchers say , WEDNESDAY, ... and geneticists have identified a genetic mutation that appears ... the most common major birth defect. , Congenital heart ... explored compared to diseases like cancer, according to study ...
... -- New research illustrates that some patients with transformed ... with few side effects. The international study, involving ... will be presented at the American Society of Clinical ... in Chicago. Forty-five percent of patients with ...
... PHILADELPHIA - Genetic researchers from the University of Pennsylvania ... of Africa with human genetic data to shed light ... all human activity emerged. The study reveals not ... also the importance of having independent lines of evidence ...
... prescription under trade name Xenical and over-the-counter as Alli ... reports of rare but sometimes severe cases of liver ... for a widely used weight-loss drug. , The drug, ... Xenical and over-the-counter as Alli. , Thirteen cases of ...
Cached Medicine News:Health News:UN Foundation President Timothy E. Wirth Commends African Leaders for Renewed Commitment to the Global Fund to Fight AIDS, Tuberculosis and Malaria 2Health News:Ground-breaking study to improve quality of life and outcomes for kids born with heart defect 2Health News:Ground-breaking study to improve quality of life and outcomes for kids born with heart defect 3Health News:Gene Mutation Linked to Congenital Heart Disease 2Health News:Study identifies promising treatment for aggressive lymphoma 2Health News:Genetic data added to archaeology and linguistics to get picture of African population history 2Health News:Genetic data added to archaeology and linguistics to get picture of African population history 3Health News:Rare Cases of Liver Damage Tied to Weight-Loss Drug 2Health News:Rare Cases of Liver Damage Tied to Weight-Loss Drug 3
... the pioneers of surgical lighting, including ... automatic reserve bulb, an integrated surgical ... sets the standard for advanced lighting ... our latest generation surgical light ...
... SimpliCT® is an interventional guidance device ... significantly improve the accuracy of computed ... to improving accuracy, SimpliCT® also has ... of CT-guided puncture procedures including biopsies ...
Flat tip, bare fiber, no cooling, polished SMA 905, 3 meters long. Sold in boxes of five. Each part is individually packaged in sterile Tyvek bags....
Get YAG laser performance from your diode laser. Our proprietary NA shift technology offers efficient coupling of low divergence fiber to high divergence lasers...
Medicine Products: